Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while YieldMax Universe Fund of Option Income ETFs trades at $7.5 (market cap $369.61M). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 4.6× YieldMax Universe Fund of Option Income ETFs's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and YieldMax Universe Fund of Option Income ETFs for 55 Days on average.
| NUVB | YMAX | |
|---|---|---|
Market Cap | $1.71B | $369.61M |
Volume | 5,448,712 | 659,132 |
Sector | Health | Income / Options Overlay |
52-Week High | $9.54 | $12.98 |
52-Week Low | $3.41 | $7.27 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $1.30B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YMAX trades at $7.53, down 1.83% on the day, with a bearish technical signal driven by moving averages. The ETF maintains a high distribution yield with weekly dividends, though recent coverage highlights concerns about NAV erosion and sustainability. Technical indicators show mixed signals with RSI neutral but ADX suggesting selling pressure, while support levels cluster around $7-8.
The outlook remains cautious due to structural concerns about distribution sustainability and NAV performance. While the high yield attracts income investors, the fund faces risks from its fee structure and portfolio strategy. Analyst sentiment appears mixed with some highlighting yield benefits while others warn of principal erosion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
